/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Association of baseline and longitudinal changes in cardiometabolic health with risk of heart failure among adults with type 2 diabetes: an analysis from the Look AHEAD trial
Event: ESC Congress 2022
Topic: Prevention
Session: Heart failure: prevention is better than cure!
Efficacy of ertugliflozin on hospitalisation for heart failure across the distribution of pre-trial ejection fraction: post hoc analyses of the VERTIS CV trial
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: SGLT2 inhibitors: pearls from recent trials and surveys
ESC 365 is supported by
